|
Chan, Linda W; Moses, Marsha A; Goley, Elizabeth et al. (2004) Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy. J Clin Oncol 22:499-506
|
|
Camphausen, Kevin; Sproull, Mary; Tantama, Steve et al. (2003) Evaluation of copper chelation agents as anti-angiogenic therapy. Bioorg Med Chem 11:4287-93
|
|
Coleman, C Norman (2003) Linking radiation oncology and imaging through molecular biology (or now that therapy and diagnosis have separated, it's time to get together again!). Radiology 228:29-35
|
|
Coleman, C Norman; Blakely, William F; Fike, John R et al. (2003) Molecular and cellular biology of moderate-dose (1-10 Gy) radiation and potential mechanisms of radiation protection: report of a workshop at Bethesda, Maryland, December 17-18, 2001. Radiat Res 159:812-34
|
|
Chakraborty, Mala; Abrams, Scott I; Camphausen, Kevin et al. (2003) Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy. J Immunol 170:6338-47
|
|
Marcus, Karen J; Dutton, Sharon C; Barnes, Patrick et al. (2003) A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma. Int J Radiat Oncol Biol Phys 55:1182-5
|
|
Colevas, A Dimitrios; Brown, J Martin; Hahn, Stephen et al. (2003) Development of investigational radiation modifiers. J Natl Cancer Inst 95:646-51
|
|
Tofilon, Philip J; Saxman, Scott; Coleman, C Norman (2003) Molecular targets for radiation therapy: bringing preclinical data into clinical trials. Clin Cancer Res 9:3518-20
|
|
Menard, Cynthia; Camphausen, Kevin; Muanza, Thierry et al. (2003) Clinical trial of endorectal amifostine for radioprotection in patients with prostate cancer: rationale and early results. Semin Oncol 30:63-7
|
|
Palayoor, Sanjeewani T; Tofilon, Philip J; Coleman, C Norman (2003) Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells. Clin Cancer Res 9:3150-7
|
Showing the most recent 10 out of 13 publications
